Bioclub
15
1M
13
2.50
3
0.13
- Areas of investment
Summary
In 2015 was created Bioclub, which is appeared as Corporate Investor. The company was established in Asia in China. The main office of represented Corporate Investor is situated in the Hangzhou.
The standard case for the fund is to invest in rounds with 1 partaker. In the next rounds fund is usually obtained by IDG Capital.
The high activity for fund was in 2017. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 1 - 5 millions dollars.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Fitness, Health Care. Among the various public portfolio startups of the fund, we may underline Yuce Biological Technology
Investments analytics
Analytics
- Total investments
- 15
- Lead investments
- 3
- Rounds per year
- 2.50
- Follow on index
- 0.13
- Investments by industry
- Health Care (9)
- Medical (9)
- Information Technology (4)
- Database (3)
- Artificial Intelligence (3) Show 17 more
- Investments by region
-
- China (15)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Group Appearance index
- 0.47
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Gig Forces | 25 May 2017 | Commercial, Information Technology, Health Care, mHealth, Dental, Staffing Agency | Seed | 975K | United States, Oregon, Portland |
| Howard | 16 Dec 2018 | Real Estate, Software, Hospitality | Seed | 2M | United States, New York |
| iFertility | 04 Nov 2015 | Health Care, Education, Fertility | Seed | 463K | Zhejiang, Shangcheng District, China |
| iNeuro | 26 Jan 2016 | Analytics, Medical, Hardware, Wearables | Seed | 463K | China, Zhejiang, Shangcheng District |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.